CRISPR THERAPEUTICS LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 1CG for the last quarter is 467.10 k EUR, and it's 99.74% lower compared to the previous quarter. The net income of Q1 24 is -108.05 M EUR.